This is the basis of anti-IL-10 strategies which have therapeutic potential if added topically after surgical debridement, which resets chronic wounds into acute fresh wounds [18]. However, IL-10, which is vital in the proliferation and remodeling phases, is deficient during these very phases of DM wound healing. The gene discussed is IL10; the disease is diabetes mellitus.